ClinicalTrials.Veeva

Menu

A Dietary Supplement Examined for Anti-ageing Effects

P

Prenetics Global

Status

Not yet enrolling

Conditions

Ageing Signs

Treatments

Dietary Supplement: Longevity pill

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT06714162
PR20240502

Details and patient eligibility

About

dietary supplement for healthy ageing

Enrollment

30 estimated patients

Sex

All

Ages

35 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Healthy Adults -

Exclusion Criteria: Diseases deemed to be unable to participate in the study

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Experimental
Experimental group
Description:
dietary supplement
Treatment:
Dietary Supplement: Longevity pill

Trial contacts and locations

0

Loading...

Central trial contact

John Ademola, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems